TITLE:
A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

CONDITION:
Secondary Hyperparathyroidism

INTERVENTION:
AMG 073

SUMMARY:

      This 6 month long study will assess an investigational medication for patients on dialysis
      with secondary hyperparathyroidism. The study will look at the effects on parathyroid
      hormone, calcium and phosphorus levels.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        -  Patients must be receiving hemodialysis; * Have elevated parathyroid hormone levels;
             * Not be pregnant or nursing; and * Not have had a heart attack in the last 3 months.
      
